Keywords: s-p, initiate, ph, iii, boceprevir, program, drug

S-P to initiate Ph III boceprevir program

Article | 02 June 2008

Print This

US drug major Schering-Plough has announced plans to initiate two large-scale Phase III studies of its investigational oral hepatitis C ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in